| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 510 |
| 1 | RUXOLITINIB | 502 |
| 2 | ASPIRIN | 335 |
| 3 | ASPIRIN 325 MG | 328 |
| 4 | ASPIRIN 81 MG | 328 |
| 5 | DARBEPOETIN ALFA | 313 |
| 6 | PREDNISONE | 308 |
| 7 | VENETOCLAX | 288 |
| 8 | ACETAMINOPHEN | 266 |
| 9 | DEXAMETHASONE | 259 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INDIUM IN -111 PENTETREOTIDE | 16 | 0.1250 |
| 1 | PINDOLOL | 22 | 0.0273 |
| 2 | MITAPIVAT | 31 | 0.0233 |
| 3 | SUTIMLIMAB-JOME | 5 | 0.0156 |
| 4 | PACRITINIB | 36 | 0.0117 |
| 5 | DANICOPAN | 3 | 0.0097 |
| 6 | EPOETIN ALFA | 113 | 0.0096 |
| 7 | ECULIZUMAB | 510 | 0.0094 |
| 8 | PEGCETACOPLAN | 17 | 0.0090 |
| 9 | ERYTHROPOIETIN | 184 | 0.0090 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 920 |
| 1 | Corticosteroid [EPC] | 713 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 615 |
| 3 | Janus Kinase Inhibitor [EPC] | 609 |
| 4 | Complement Inhibitor [EPC] | 547 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 340 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 327 |
| 7 | Proton Pump Inhibitor [EPC] | 319 |
| 8 | Erythropoiesis-stimulating Agent [EPC] | 313 |
| 9 | Vitamin C [EPC] | 306 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Pyruvate Kinase Activator [EPC] | 31 | 0.0233 |
| 1 | Interleukin-5 Antagonist [EPC] | 13 | 0.0189 |
| 2 | Photoactivated Radical Generator [EPC] | 2 | 0.0156 |
| 3 | Classical Complement Pathway Inhibitor [EPC] | 5 | 0.0156 |
| 4 | Complement Inhibitor [EPC] | 547 | 0.0097 |
| 5 | Complement Factor D Inhibitor [EPC] | 3 | 0.0097 |
| 6 | Provitamin D2 Compound [EPC] | 211 | 0.0071 |
| 7 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 14 | 0.0062 |
| 8 | Erythropoiesis-stimulating Agent [EPC] | 313 | 0.0058 |
| 9 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 11 | 0.0051 |